register free | resend password

RavenQuest issues statement in response to health Canada sales license suspension at bonify

ID: 1546581
recent pressrelease next pressrelease

(PresseBox) - RavenQuest BioMed Inc. (the ?Company? or ?RavenQuest?) ? (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT - CEO, George Robinson, also acting President & CEO at Bonify, issues the following statement in response to the February 4 Health Canada (?HC?) Notice of Suspension for Sales at Bonify Holdings Corporation (?Bonify?).

?On February 4, 2019, Bonify received a Notice of Suspension for Sales from Health Canada.hat we received in the written Notice of Suspension.

Health Canada hand delivered the Notice of Suspension at 9:30am, February 4, prior to the two-day inspection that took place on February 4-5, 2019.

Bonify initiated a recall of product and began corrective action immediately

December 11-14, 2018: HC inspects the Bonify facility

December 14, 2018: Bonify begins additional corrective actions based upon HC verbal debrief

December 21, 2018: HC reports written findings to Bonify

January 9: Bonify responds to HC?s observations

January 19: HC requests additional information with a February 1 due date, later extended to February 11 at Bonify?s request

February 4: HC delivers Notice of Suspension to Bonify prior to the Bonify facility inspection

Bonify is entitled to respond to the Notice of Suspension within 10 days and will vigorously defend its license by providing reasons why the suspension is unfounded?.

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.

RavenQuest maintains a research partnership with Montreal?s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.

On Behalf of the Board of Directors of

?George Robinson?

Chief Executive Officer

For further information, please contact:

Mathieu McDonald, Corporate Communications ? 1-877-282-1568

In Europe:

Swiss Resource Capital AG

Jochen Staiger


Neither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are ?forward-looking information? with respect to the Company within the meaning of applicable securities laws, including statements with respect to the development of licensed cannabis production facilities, the production and supply of cannabis to the BCLDB, .the launch of consumer cannabis brands and the development of partnerships with Indigenous communities.ks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieveiffer materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could

More information:

Keywords (optional):

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: PresseBox
print pressrelease  send to a friend  

Date: 02/08/2019 - 08:21
Language: English
News-ID 1546581
Character count: 5330
Firma: Swiss Resource Capital AG
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Vancouver, British Columbia


Number of hits: 415


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 47

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.